首页> 外文会议>World biomaterials congress >Microdroplet-based 3D gastric cancer model for evaluation of drug resistance
【24h】

Microdroplet-based 3D gastric cancer model for evaluation of drug resistance

机译:基于微型方法的3D胃癌模型,用于评估耐药性

获取原文

摘要

Gastric cancer is aggressive malignant tumor with high incidence and mortality in worldwide despite the recent advances in anti-cancer drugs.1 According to the morphological features, Lauren's classification distinguishes two types of gastric cancer, intestinal and diffuse types. Since diffuse- and intestinal-type gastric cancers show distinctly different clinicopathological features, new strategy for the cancer therapy depending on the two pathological variants of gastric cancer is necessary in in vitro preclinical models. 1 For advanced in vitro preclinical model, we performed droplet-based microfluidics to construct and characterize in vitro 3D gastric cancer model depending on two different types. To evaluate proposed 3D gastric cancer models, we confirmed cell morphology in ECM bead, and changes in expression of drug resistance-related protein, as well as drug resistance against anticancer drug, 5-fluorouracil (5-FU). The generation of 3D microbeads, consisting of cells embedded in an extracellular matrix (ECM), was carried out in flow-focusing device. To prevent ECM gelation during droplet formation, the flow-focusing device was maintained below 10°C. The oil and the ECM solution with gastric cancer cells were injected as a continuous phase and the disperse phase, respectively. AGS (intestinal type) and HS746T (diffuse type) were utilized in this system for realization of two different types of gastric cancer. The cell morphology observed through F-actin and nucleus staining and viability was examined by LIVE/DEAD cell staining. For further investigations, we performed the chemoresistance against 5-FU using WST-1 cell proliferation assay, and mRNA and protein expression of K-catenin was examined by RT-qPCR and western blot. To construct 3D gastric cancer model, we fabricated ECM microbead by flow-focusing technique to make size-controllable microbeads. We identified high cell viability after 7 days through LIVE/DEAD cell staining. The two different gastric cancer cell lines displayed different phenotypes in collagen bead. AGS represents spheroid formation with expansive growth. On the other hand, HS746T shows a single cell migration with infiltrative growth pattern, and consists of scattered cells.2 Expression of SS-catenin is differently expressed in 2D and 3D culture. Interestingly, tower SS-catenin protein expression was associated with lack of histological response to chemotherapy, and with resistance to 5-FU in gastric cancer. Conclusively, we developed in vitro 3D gastric cancer model system for analysis and confirmation of morphology, and drug resistance in ECM beads. Our results suggest that in vitro 3D models of gastric cancer represent a biologically relevant platform for studying gastric cancer cell biology, tumorigenesis, and for accelerating the development of novel therapeutic targets. We believe that the microdroplet-cancer model is highly suitable to prove useful in high-throughput drug testing and screening for preclinical 3D cell culture platform.
机译:胃癌是侵袭性恶性肿瘤,在全球性发病率高,尽管抗癌药物的进步是抗癌药物的进步.1根据形态学特征,Lauren的分类区分了两种类型的胃癌,肠道和弥漫性。由于弥漫性和肠型胃癌显示出明显不同的临床病理特征,因此在体外临床前模型需要根据胃癌的两种病理变异的癌症治疗的新策略。 1对于先进的体外临床前模型,我们进行了基于液滴的微流体,以根据两种不同类型构建和表征体外3D胃癌模型。为了评估所提出的3D胃癌模型,我们确认了ECM珠粒中的细胞形态,以及耐药相关蛋白表达的变化,以及针对抗癌药物,5-氟尿嘧啶(5-FU)的耐药性。在流动聚焦装置中进行由嵌入细胞外基质(ECM)中的细胞组成的3D微珠的产生。为了防止液滴形成期间的ECM凝胶化,流动聚焦装置保持在10℃以下。将具有胃癌细胞的油和ECM溶液作为连续相和分散相。在该系统中使用AGS(肠型)和HS746T(漫反射型)以实现两种不同类型的胃癌。通过活/死细胞染色检查通过F-actin和核染色和生存力观察到的细胞形态。为了进一步研究,我们使用WST-1细胞增殖测定对5-FU进行化学抑制,并通过RT-QPCR和Western印迹检查K-Catenin的mRNA和蛋白表达。为了构建3D胃癌模型,我们通过流动聚焦技术制造了ECM Microbead,以制备尺寸可控的微珠。通过活/死细胞染色,我们在7天后确定了高细胞活力。两种不同的胃癌细胞系在胶原珠中显示出不同的表型。 AGS表示具有膨胀生长的球状形成。另一方面,HS746T显示出具有渗透生长模式的单细胞迁移,并且由散射的细胞组成.2 SS-Catenin的表达在2D和3D培养物中不同地表达。有趣的是,塔SS-catenin蛋白表达与缺乏对化疗的组织学反应相关,胃癌中的5-FU患者有关。结论,我们开发了体外3D胃癌模型系统,用于分析和确认形态,ECM珠粒中的耐药性。我们的研究结果表明,胃癌的体外3D模型代表了学习胃癌细胞生物学,肿瘤瘤的生物相关平台,以及加速新的治疗靶标的发展。我们认为微滴血模型非常适合在临床前3D细胞培养平台上证明在高通量药物测试和筛选中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号